Dietary vitamin A and its derivatives, retinoids, regulate cardiac growth and development. To delineate mechanisms involved in retinoid-mediated control of cardiac gene expression, the regulatory effects of the retinoid X receptor ␣ (RXR␣) on atrial naturietic factor (ANF) gene transcription was investigated. The transcriptional activity of an ANF promoter-reporter in rat neonatal ventricular myocytes was repressed by RXR␣ in the presence of 9-cis-RA and by the constitutively active mutant RXR␣F318A indicating that liganded RXR confers the regulatory effect. The RXR␣-mediated repression mapped to the proximal 147 bp of the rat ANF promoter, a region lacking a consensus retinoid response element but containing several known cardiogenic cis elements including a well characterized GATA response element. Glutathione S-transferase "pulldown" assays revealed that RXR␣ interacts directly with GATA-4, in a ligand-independent manner, via the DNA binding domain of RXR␣ and the second zinc finger of GATA-4. Liganded RXR␣ repressed the activity of a heterologous promoter-reporter construct containing GATA-response element recognition sites in cardiac myocytes but not in several other cell types, suggesting that additional cardiac-enriched factors participate in the repression complex. Co-transfection of liganded RXR␣ and the known cardiac-enriched GATA-4 repressor, FOG-2, resulted in additive repression of GATA-4 activity in ventricular myocytes. In addition, RXR␣ was found to bind FOG-2, in a 9-cis-RA-dependent manner. These data reveal a novel mechanism by which retinoids regulate cardiogenic gene expression through direct interaction with GATA-4 and its co-repressor, FOG-2.Retinoids are compounds, derived from vitamin A, which exert pleiotropic effects on cellular differentiation, morphogenesis, and metabolism. The effects of retinoids on cardiac growth and development are well recognized. Offspring of rodents and birds fed a vitamin A-deficient diet display congenital defects involving many organ systems including the cardiovascular system (1, 2). Vitamin A replacement at different stages of embryonic development in these animals actually alters the severity and type of heart defects seen at birth indicating that retinoid signaling pathways play key roles in a variety of developmental programs (1). Similarly, retinaldehyde dehydrogenase-deficient mice die in utero at embryonic day 8 secondary to poor maturation of the ventricular myocardium, an effect that can be rescued by supplementation of maternal vitamin A (3, 4). In addition, retinoids can exert teratogenic effects. Human offspring born of mothers who ingested isotretinoin, a vitamin A analog, during pregnancy exhibited a high incidence of complex cardiac malformations including transposition of the great vessels, tetralogy of Fallot, hypoplastic aortic arch, and ventricular septal defects (5). Moreover, in the developing chick, local application of high concentrations of retinoic acid disrupts the migration of the pre-cardiac mesoderm, an effect that is dose-depe...